Through a comprehensive analysis of Tumor ImmuneScore, StromalScore, and ESTIMATEScore (Supplementary Figs. S7, S8 and S9), we observed a negative correlation between HSP90B1 expression and tumor purity in BLCA, KIRC, and PCPG (all p < 0.05). Here, HSP90B1 is linked to neoplasm.